Metabolic Treatment of Cancer: Intermediate Results of a Prospective Case Series - 0 views
-
Nathan Goodyear on 08 Sep 14advanced, end-stage cancer treated in few patients with IV alpha lipoic acid, oral LDN, and hydroxycitrate--case study presentation. The therapies were well tolerated without toxicity. The authors concluded that the therapy "enhances the efficacy" of the chemotherapy.